Histological analysis of IL-2 induced regression of murine solid SL2-tumors Riks A. MaasHub F. J. DullensWillem Den Otter Research Articles Pages: 83 - 91
Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation Ben Trijzelaar Research Articles Pages: 93 - 102
Augmentation of antitumor immunity in regional lymph nodes by local immunotherapy Isao SakitaTakushi MondenTakesada Mori Research Articles Pages: 103 - 112
Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria Monocytogenes P. M. B. MelissenW. van VianenI. A. J. M. Bakker-Woudenberg Research Articles Pages: 113 - 124
Prevention of doxorubicin-induced cardiotoxicity by recombinant interleukin-1 in hamsters Takashi YoshidaHirokazu OkumuraTamotsu Matsuda Research Articles Pages: 125 - 132
Effect of postoperative intrapleural instillations of interleukin-2 in patients with malignant pleurisy due to lung cancer Kosei YasumotoAkira NagashimaKikuo Nomoto Research Articles Pages: 133 - 138
The comparative effects of IL-1 and TNF on AMN-anti-Ly 2.1 immunoconjugate therapy Kenia G KrauerGeoffrey A Pietersz Research Articles Pages: 139 - 147
Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemia Shigeru ArimoriHideo TeradaKeiichi Harada Research Articles Pages: 149 - 153
Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas Mamoru TsukudaIzumi MochimatsuAkira Kubota Research Articles Pages: 155 - 161